AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ONCOSIL MEDICAL LTD

1.150

-0.030-2.54%

Volume:78.16K

Turnover:90.14K

Market Cap:35.52M

PE:-1.22

High:1.190

Open:1.175

Low:1.135

Close:1.180

52wk High:2.090

52wk Low:0.370

Shares:30.89M

Float Shares:16.80M

Volume Ratio:0.20

T/O Rate:0.47%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.940

EPS(LYR):-1.382

ROE:-208.41%

ROA:-87.11%

PB:9.26

PE(LYR):-0.83

Loading ...

Overview Company News Filings

Oncosil Medical - FDA Grants Hde Approval for Oncosil Device for Distal Cholangiocarcinoma

THOMSON REUTERS

Oncosil Medical - FY26 Unit Sales up 53%, Revenue up 44% Versus FY25

THOMSON REUTERS

Oncosil Medical Ltd-new Independent Study Confirms Oncosil Dose Flexibility

THOMSON REUTERS

Oncosil Medical Ltd - Oncosil Medical Receives Saudi FDA Approval

THOMSON REUTERS

Oncosil Medical Files for FDA Approval

Oncosil Medical Files for FDA Approval

Oncosil Medical - Oncosil Device Enters FDA Review Phase for Commercial Approval

THOMSON REUTERS

Oncosil Medical - FDA Review Expected to Complete Within 45 Days of Submission

THOMSON REUTERS

Taylor Collison Starts OncoSil Medical at Speculative Buy with AU$1.46 Price Target

MT Newswires Live

Oncosil Medical Ltd-US FDA Hde and Tripp-Ffx Study Presentation

THOMSON REUTERS

Oncosil Medical Ltd-Oncosil Progresses Hde With US FDA

THOMSON REUTERS

BRIEF-Oncosil Medical Seeks Trading Halt

Oncosil Medical - Trading Halt Pending Announcement on Tripp-Ffx Trial Results and FDA Correspondence

THOMSON REUTERS

Oncosil Medical Ltd-Appointment of Company Secretary

THOMSON REUTERS

OncoSil Medical Says Encouraging Pancreatic Cancer Therapy Data to Be Presented at Chicago Conference; Shares Gain 13%

MT Newswires Live

OSL Strengthens Asia’s Digital Asset Ecosystem with Listing of State-Supervised Gold-Backed Stablecoin USDKG

BRIEF-Oncosil Medical Receives TGA Approval In Australia

BUZZ-Australia's OncoSil Medical soars on regulatory nod for cancer device

Oncosil Medical Ltd - Receives Tga Approval for Oncosil Device for Pancreatic Cancer in Australia

THOMSON REUTERS

Oncosil Medical Ltd - Oncosil Medical Receives Tga Approval in Australia

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/OSL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","market":"AU","secType":"STK","nameCN":"ONCOSIL MEDICAL LTD","latestPrice":1.15,"timestamp":1787292720000,"preClose":1.18,"halted":0,"volume":78161,"delay":0,"changeRate":-0.025423728813559344,"nameEN":"ONCOSIL MEDICAL LTD","floatShares":16797755,"shares":30888898,"eps":-0.94,"marketStatus":"Market Closed","change":-0.03,"latestTime":"08-21 16:12:00 AEST","open":1.175,"high":1.19,"low":1.135,"amount":90141,"amplitude":0.04661,"askPrice":1.155,"askSize":9161,"bidPrice":1.1,"bidSize":909,"shortable":3,"etf":0,"ttmEps":-0.94,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":1.18,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.19634742194849236,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"OSL.AU","preClose":1.18,"auctionPrice":1.15,"auctionVolume":1474,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292593784}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSL.AU\",,,,,undefined,":{"symbol":"OSL.AU","floatShares":16797755,"roa":"-87.11%","roe":"-208.41%","lyrEps":-1.381715,"volumeRatio":0.19634742194849236,"shares":30888898,"dividePrice":0,"high":1.19,"amplitude":0.04661,"preClose":1.18,"low":1.135,"week52Low":0.37,"pbRate":"9.26","psRate":"9.54","week52High":2.09,"institutionHeld":0,"latestPrice":1.15,"committee":-0.819464,"eps":-0.94,"divideRate":0,"volume":78161,"delay":0,"ttmEps":-0.94,"open":1.175,"prevYearClose":0.97,"prevWeekClose":1.27,"prevMonthClose":1.16,"prevQuarterClose":0.71,"fiveDayClose":1.27,"twentyDayClose":1.205,"sixtyDayClose":0.49,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-06-03","symbol":"OSL.AU","defaultRemindTime":1748908800000,"type":"split","dateTimestamp":1748872800000,"forFactor":400,"toFactor":1,"ratio":400},{"market":"AU","date":"2022-05-05","symbol":"OSL.AU","defaultRemindTime":1651708800000,"type":"split","dateTimestamp":1651672800000,"forFactor":987878,"toFactor":1000000,"ratio":0.987878}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660820103","title":"Oncosil Medical - FDA Grants Hde Approval for Oncosil Device for Distal Cholangiocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2660820103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660820103?lang=en_us&edition=fundamental","pubTime":"2026-08-17 06:36","pubTimestamp":1786919772,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nFWN44C06B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","OSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655103238","title":"Oncosil Medical - FY26 Unit Sales up 53%, Revenue up 44% Versus FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2655103238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655103238?lang=en_us&edition=fundamental","pubTime":"2026-07-30 06:43","pubTimestamp":1785365003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V1OY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSL.AU","BK7048","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653717847","title":"Oncosil Medical Ltd-new Independent Study Confirms Oncosil Dose Flexibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2653717847","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653717847?lang=en_us&edition=fundamental","pubTime":"2026-07-24 06:41","pubTimestamp":1784846460,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nTUE7KXW7C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSL.AU","BK7048","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652776250","title":"Oncosil Medical Ltd - Oncosil Medical Receives Saudi FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2652776250","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652776250?lang=en_us&edition=fundamental","pubTime":"2026-07-20 06:31","pubTimestamp":1784500317,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260719:nFWN43K034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","OSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649838319","title":"Oncosil Medical Files for FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2649838319","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649838319?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:44","pubTimestamp":1783413852,"startTime":"0","endTime":"0","summary":"July 3 (Reuters) - Oncosil Medical Ltd::*ONCOSIL MEDICAL FILES FOR FDA APPROVAL*ONCOSIL DEVICE ENTERS FDA REVIEW PHASE FOR COMMERCIAL APPROVAL*FDA REVIEW EXPECTED TO COMPLETE WITHIN 45 DAYS OF SUBMISS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nRSD3qC7bd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","OSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648390666","title":"Oncosil Medical Files for FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2648390666","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648390666?lang=en_us&edition=fundamental","pubTime":"2026-07-03 07:35","pubTimestamp":1783035336,"startTime":"0","endTime":"0","summary":"BRIEF-Oncosil Medical Files For FDA ApprovalJuly 3 (Reuters)-Oncosil Medical LtdOSL.AX:ONCOSIL MEDICAL FILES FOR FDA APPROVALONCOSIL DEVICE ENTERS FDA REVIEW PHASE FOR COMMERCIAL APPROVALFDA REVIEW EXPECTED TO COMPLETE WITHIN 45 DAYS OF SUBMISSIONFurther company coverage:OSL.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE4MSQ6M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","OSL.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648763605","title":"Oncosil Medical - Oncosil Device Enters FDA Review Phase for Commercial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2648763605","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648763605?lang=en_us&edition=fundamental","pubTime":"2026-07-03 06:27","pubTimestamp":1783031246,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE4MSQ6M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSL.AU","BK7048","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648636054","title":"Oncosil Medical - FDA Review Expected to Complete Within 45 Days of Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2648636054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648636054?lang=en_us&edition=fundamental","pubTime":"2026-07-03 06:27","pubTimestamp":1783031246,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE4MSQ6M:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSL.AU","BK7048","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645892572","title":"Taylor Collison Starts OncoSil Medical at Speculative Buy with AU$1.46 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2645892572","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645892572?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:50","pubTimestamp":1782298254,"startTime":"0","endTime":"0","summary":"Taylor Collison Starts OncoSil Medical at Speculative Buy with AU$1.46 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","OSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642303314","title":"Oncosil Medical Ltd-US FDA Hde and Tripp-Ffx Study Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2642303314","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642303314?lang=en_us&edition=fundamental","pubTime":"2026-06-09 07:48","pubTimestamp":1780962516,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUE8FW4QP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7508","OSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642332430","title":"Oncosil Medical Ltd-Oncosil Progresses Hde With US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2642332430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642332430?lang=en_us&edition=fundamental","pubTime":"2026-06-09 07:48","pubTimestamp":1780962496,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUE5XXQMZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","OSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640187779","title":"BRIEF-Oncosil Medical Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2640187779","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640187779?lang=en_us&edition=fundamental","pubTime":"2026-06-04 07:10","pubTimestamp":1780528230,"startTime":"0","endTime":"0","summary":"BRIEF-Oncosil Medical Seeks Trading Halt June 4 (Reuters) - Oncosil Medical Ltd OSL.AX:TRADING HALT PENDING ANNOUNCEMENT ON TRIPP-FFX TRIAL RESULTS AND FDA CORRESPONDENCEFurther company coverage: OSL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0UB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","OSL.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640187713","title":"Oncosil Medical - Trading Halt Pending Announcement on Tripp-Ffx Trial Results and FDA Correspondence","url":"https://stock-news.laohu8.com/highlight/detail?id=2640187713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640187713?lang=en_us&edition=fundamental","pubTime":"2026-06-04 07:09","pubTimestamp":1780528197,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0UB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","OSL.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638738587","title":"Oncosil Medical Ltd-Appointment of Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2638738587","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638738587?lang=en_us&edition=fundamental","pubTime":"2026-05-25 13:49","pubTimestamp":1779688148,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nTUE9GSZZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSL.AU","BK7508","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637361551","title":"OncoSil Medical Says Encouraging Pancreatic Cancer Therapy Data to Be Presented at Chicago Conference; Shares Gain 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637361551","media":"MT Newswires Live","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637361551?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:59","pubTimestamp":1779415192,"startTime":"0","endTime":"0","summary":"OncoSil Medical  said data highlighting the \"excellent safety\" of its OncoSil device for the treatment of pancreatic cancer will be presented at an American Society of Clinical Oncology conference in Chicago on May 30, according to a Friday filing with the Australian bourse.The data to be presented shows \"a high percentage of surgical resection rates\" achieved in locally advanced pancreatic cancer patients who were deemed unresectable at diagnosis, per the filing.The treatment with the OncoSil device showed a favorable safety profile and a median progression-free survival of 8.5 months, the company said.Shares of OncoSil Medical advanced nearly 13% in recent Friday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","OSL.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637275390","title":"OSL Strengthens Asia’s Digital Asset Ecosystem with Listing of State-Supervised Gold-Backed Stablecoin USDKG","url":"https://stock-news.laohu8.com/highlight/detail?id=2637275390","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637275390?lang=en_us&edition=fundamental","pubTime":"2026-05-21 10:14","pubTimestamp":1779329640,"startTime":"0","endTime":"0","summary":"Hong Kong, Hong Kong, May 21st, 2026, ChainwireOSL Group (863.HK) (OSL), a global stablecoin payment and trading platform, today announced that its Hong Kong-licensed digital asset exchange OSL HK has","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/press-releases/osl-strengthens-asias-digital-asset-ecosystem-with-listing-of-state-supervised-gold","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/press-releases/osl-strengthens-asias-digital-asset-ecosystem-with-listing-of-state-supervised-gold","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["LU2360107671.USD","LU1668664300.SGD","LU1861217088.USD","LU1894683264.USD","CRCA","IE0034235188.USD","LU1894683348.USD","LU0061475181.USD","CCUP","BK4588","BEGS","CRCO","BK4135","CRCL","LU1861558580.USD","CRCD","LU1861220207.SGD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU1861559042.SGD","ICRC","STT","BK4023","LU0106831901.USD","LU1791807156.HKD","BK4585","IE00BGHQF748.EUR","LU1883839398.USD","OSL.AU","CRCG","BK7508","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636813105","title":"BRIEF-Oncosil Medical Receives TGA Approval In Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2636813105","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636813105?lang=en_us&edition=fundamental","pubTime":"2026-05-20 14:07","pubTimestamp":1779257233,"startTime":"0","endTime":"0","summary":"BRIEF-Oncosil Medical Receives TGA Approval In AustraliaMay 20 (Reuters) - Oncosil Medical Ltd OSL.AX:ONCOSIL MEDICAL RECEIVES TGA APPROVAL IN AUSTRALIARECEIVES TGA APPROVAL FOR ONCOSIL DEVICE FOR PANCREATIC CANCER IN AUSTRALIAFurther company coverage: OSL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nFWN41W0UW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSL.AU","BK7048","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636893708","title":"BUZZ-Australia's OncoSil Medical soars on regulatory nod for cancer device","url":"https://stock-news.laohu8.com/highlight/detail?id=2636893708","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636893708?lang=en_us&edition=fundamental","pubTime":"2026-05-20 08:27","pubTimestamp":1779236840,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's OncoSil Medical soars on regulatory nod for cancer device ** Shares of Australia's OncoSil Medical OSL.AX rise as much as 46.2% to A$0.570, logging their best intraday pct gain since June 2, 2025** Stock hits its highest level since March 16** Medical device firm receives approval from Australian Therapeutic Goods Administration  for OncoSil device for treatment of pancreatic cancer in Australia** Says device targets tumours directly within pancreas** TGA is the Australian government's regulatory agency for medical products** Stock down 45% this year, including the day's move  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4N41X017:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","OSL.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636898339","title":"Oncosil Medical Ltd - Receives Tga Approval for Oncosil Device for Pancreatic Cancer in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2636898339","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636898339?lang=en_us&edition=fundamental","pubTime":"2026-05-20 07:17","pubTimestamp":1779232641,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W0UW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","OSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636898336","title":"Oncosil Medical Ltd - Oncosil Medical Receives Tga Approval in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2636898336","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636898336?lang=en_us&edition=fundamental","pubTime":"2026-05-20 07:17","pubTimestamp":1779232641,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W0UW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSL.AU","BK7508","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}